Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China
Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
BMJ Open. 2020 Nov 26;10(11):e039397. doi: 10.1136/bmjopen-2020-039397.
To estimate and report the minimally important difference (MID) of the EuroQol five-dimensional five-level questionnaire (EQ-5D-5L) using the Hong Kong (HK) utility score among patients with either hypertension or diabetes or both.
Data were analysed using secondary data analysis based on a cross-sectional study assessing patients' experiences in HK.
A representative sample was recruited from 26 specialist outpatient clinics in HK.
We analysed data from 2231 and 662 patients who reported having hypertension or diabetes alone, respectively, and 874 patients had these two diseases.
An instrument-defined approach was applied to estimate MID stratified according to sex and age for the three subpopulations.
The overall MID (oMID) estimates were 0.089, 0.086 and 0.089 for patients with hypertension or diabetes alone and with these two diseases, respectively. The adjusted MID (aMID) estimate was smaller than the oMID, and the improved MID was larger than the deteriorated MID. Women had larger oMID but smaller aMID than men. Younger respondents had larger aMID than older respondents. Effect sizes ranged from 0.30 to 0.503, which fit our preset criteria.
Four types of MID of the EQ-5D utility score for patients with hypertension or diabetes alone and with these two diseases were reported. Variations in the MID estimates should be further explored in other populations or using different statistical methods.
使用香港(HK)效用得分估计并报告欧洲五维健康量表五维问卷(EQ-5D-5L)在患有高血压或糖尿病或两者兼有患者中的最小重要差异(MID)。
使用基于横断面研究评估患者在香港经历的二次数据分析数据。
从香港 26 个专科门诊招募了一个代表性样本。
我们分析了分别报告患有高血压或糖尿病或同时患有这两种疾病的 2231 名和 662 名患者的数据,以及 874 名患有这两种疾病的患者的数据。
根据三个亚组的性别和年龄,应用仪器定义方法估计 MID。
患有高血压或糖尿病或同时患有这两种疾病的患者的总体 MID(oMID)估计值分别为 0.089、0.086 和 0.089。调整后的 MID(aMID)估计值小于 oMID,改善的 MID 大于恶化的 MID。女性的 oMID 大于男性,但 aMID 小于男性。年轻的受访者比年长的受访者有更大的 aMID。效应大小范围从 0.30 到 0.503,符合我们的预设标准。
报告了单独患有高血压或糖尿病或同时患有这两种疾病的患者的 EQ-5D 效用评分的四种类型的 MID。应在其他人群或使用不同的统计方法中进一步探索 MID 估计值的变化。